US Stock MarketDetailed Quotes

ETON Eton Pharmaceutical

Watchlist
  • 10.750
  • +0.320+3.07%
Close Nov 21 16:00 ET
  • 10.750
  • 0.0000.00%
Post 20:01 ET
277.74MMarket Cap-51190P/E (TTM)

Eton Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
238.14%2.95M
-82.33%1.26M
-59.75%-2.47M
41.36%6.82M
-86.37%387K
151.26%873K
188.62%7.1M
-226.57%-1.55M
202.12%4.82M
155.50%2.84M
Net income from continuing operations
208.29%627K
-166.70%-3.04M
69.51%-811K
89.62%-936K
-347.37%-2.26M
80.99%-579K
392.62%4.56M
50.09%-2.66M
-361.43%-9.02M
-12.22%912K
Depreciation and amortization
45.55%278K
51.74%261K
18.31%252K
-49.21%901K
28.97%325K
12.35%191K
-85.31%172K
17.68%213K
283.98%1.77M
83.94%252K
Other non cash items
-2.50%39K
-16.90%59K
-13.79%25K
-7.87%117K
-174.19%-23K
33.33%40K
136.67%71K
-19.44%29K
-14.19%127K
-18.42%31K
Change In working capital
161.91%1.29M
106.86%3.14M
-137,900.00%-2.76M
-53.44%3.6M
109.62%1.59M
154.40%491K
-0.13%1.52M
-100.04%-2K
224.34%7.72M
110.55%759K
-Change in receivables
-74.45%-717K
-201.43%-633K
18.88%-829K
-143.08%-1.56M
123.73%84K
38.10%-411K
-452.63%-210K
-121.86%-1.02M
166.73%3.62M
93.04%-354K
-Change in inventory
155.32%130K
165.96%250K
-1,272.50%-1.41M
-4,957.14%-354K
284.21%140K
-570.00%-235K
-1,704.76%-379K
200.00%120K
-101.01%-7K
64.81%-76K
-Change in prepaid assets
-148.77%-159K
8.19%251K
-58.64%79K
-91.54%161K
-159.03%-588K
7.95%326K
-73.21%232K
-80.12%191K
285.38%1.9M
69.45%-227K
-Change in payables and accrued expense
150.55%2.03M
74.48%3.27M
-185.05%-603K
142.10%5.35M
38.06%1.96M
60.59%811K
163.43%1.87M
267.61%709K
586.56%2.21M
223.24%1.42M
Cash from discontinued investing activities
Operating cash flow
238.14%2.95M
-82.33%1.26M
-59.75%-2.47M
41.36%6.82M
-86.37%387K
151.26%873K
188.62%7.1M
-226.57%-1.55M
202.12%4.82M
155.50%2.84M
Investing cash flow
Cash flow from continuing investing activities
0
0
-1.88M
72.20%-775K
-6,358.33%-775K
0
0
0
-8.95%-2.79M
99.63%-12K
Net PPE purchase and sale
--0
--0
---14K
--0
--0
--0
--0
--0
-105.50%-38K
-200.00%-12K
Net intangibles purchase and sale
--0
--0
---1.87M
71.82%-775K
---775K
--0
--0
--0
15.38%-2.75M
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
---1.88M
72.20%-775K
-6,358.33%-775K
--0
--0
--0
-8.95%-2.79M
99.63%-12K
Financing cash flow
Cash flow from continuing financing activities
-4.34%-385K
11.84%-216K
-671.43%-378K
-614.18%-957K
-396.97%-294K
-1,154.29%-369K
-309.40%-245K
87.27%-49K
-134.27%-134K
45.59%99K
Net issuance payments of debt
0.00%-385K
0.00%-385K
---385K
-200.00%-1.16M
---385K
---385K
---385K
--0
-156.67%-385K
--0
Proceeds from stock option exercised by employees
--0
20.71%169K
-94.70%7K
-21.12%198K
-190.91%-90K
-54.29%16K
19.66%140K
--132K
-53.60%251K
45.59%99K
Net other financing activities
----
----
----
----
----
--0
--0
---181K
----
----
Cash from discontinued financing activities
Financing cash flow
-4.34%-385K
11.84%-216K
-671.43%-378K
-614.18%-957K
-396.97%-294K
-1,154.29%-369K
-309.40%-245K
87.27%-49K
-134.27%-134K
45.59%99K
Net cash flow
Beginning cash position
-17.95%17.69M
13.24%16.66M
31.17%21.39M
13.18%16.31M
64.97%22.07M
26.52%21.57M
-3.42%14.71M
13.18%16.31M
-32.35%14.41M
-41.09%13.38M
Current changes in cash
409.33%2.57M
-84.85%1.04M
-196.37%-4.73M
167.67%5.08M
-123.30%-682K
113.74%504K
277.44%6.86M
-294.05%-1.6M
127.57%1.9M
135.25%2.93M
End cash Position
-8.20%20.26M
-17.95%17.69M
13.24%16.66M
31.17%21.39M
31.17%21.39M
64.97%22.07M
26.52%21.57M
-3.42%14.71M
13.18%16.31M
13.18%16.31M
Free cash flow
238.14%2.95M
-82.33%1.26M
-181.33%-4.36M
197.10%6.04M
-113.72%-388K
123.58%873K
317.82%7.1M
-228.15%-1.55M
125.48%2.03M
133.78%2.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 238.14%2.95M-82.33%1.26M-59.75%-2.47M41.36%6.82M-86.37%387K151.26%873K188.62%7.1M-226.57%-1.55M202.12%4.82M155.50%2.84M
Net income from continuing operations 208.29%627K-166.70%-3.04M69.51%-811K89.62%-936K-347.37%-2.26M80.99%-579K392.62%4.56M50.09%-2.66M-361.43%-9.02M-12.22%912K
Depreciation and amortization 45.55%278K51.74%261K18.31%252K-49.21%901K28.97%325K12.35%191K-85.31%172K17.68%213K283.98%1.77M83.94%252K
Other non cash items -2.50%39K-16.90%59K-13.79%25K-7.87%117K-174.19%-23K33.33%40K136.67%71K-19.44%29K-14.19%127K-18.42%31K
Change In working capital 161.91%1.29M106.86%3.14M-137,900.00%-2.76M-53.44%3.6M109.62%1.59M154.40%491K-0.13%1.52M-100.04%-2K224.34%7.72M110.55%759K
-Change in receivables -74.45%-717K-201.43%-633K18.88%-829K-143.08%-1.56M123.73%84K38.10%-411K-452.63%-210K-121.86%-1.02M166.73%3.62M93.04%-354K
-Change in inventory 155.32%130K165.96%250K-1,272.50%-1.41M-4,957.14%-354K284.21%140K-570.00%-235K-1,704.76%-379K200.00%120K-101.01%-7K64.81%-76K
-Change in prepaid assets -148.77%-159K8.19%251K-58.64%79K-91.54%161K-159.03%-588K7.95%326K-73.21%232K-80.12%191K285.38%1.9M69.45%-227K
-Change in payables and accrued expense 150.55%2.03M74.48%3.27M-185.05%-603K142.10%5.35M38.06%1.96M60.59%811K163.43%1.87M267.61%709K586.56%2.21M223.24%1.42M
Cash from discontinued investing activities
Operating cash flow 238.14%2.95M-82.33%1.26M-59.75%-2.47M41.36%6.82M-86.37%387K151.26%873K188.62%7.1M-226.57%-1.55M202.12%4.82M155.50%2.84M
Investing cash flow
Cash flow from continuing investing activities 00-1.88M72.20%-775K-6,358.33%-775K000-8.95%-2.79M99.63%-12K
Net PPE purchase and sale --0--0---14K--0--0--0--0--0-105.50%-38K-200.00%-12K
Net intangibles purchase and sale --0--0---1.87M71.82%-775K---775K--0--0--015.38%-2.75M--0
Cash from discontinued investing activities
Investing cash flow --0--0---1.88M72.20%-775K-6,358.33%-775K--0--0--0-8.95%-2.79M99.63%-12K
Financing cash flow
Cash flow from continuing financing activities -4.34%-385K11.84%-216K-671.43%-378K-614.18%-957K-396.97%-294K-1,154.29%-369K-309.40%-245K87.27%-49K-134.27%-134K45.59%99K
Net issuance payments of debt 0.00%-385K0.00%-385K---385K-200.00%-1.16M---385K---385K---385K--0-156.67%-385K--0
Proceeds from stock option exercised by employees --020.71%169K-94.70%7K-21.12%198K-190.91%-90K-54.29%16K19.66%140K--132K-53.60%251K45.59%99K
Net other financing activities ----------------------0--0---181K--------
Cash from discontinued financing activities
Financing cash flow -4.34%-385K11.84%-216K-671.43%-378K-614.18%-957K-396.97%-294K-1,154.29%-369K-309.40%-245K87.27%-49K-134.27%-134K45.59%99K
Net cash flow
Beginning cash position -17.95%17.69M13.24%16.66M31.17%21.39M13.18%16.31M64.97%22.07M26.52%21.57M-3.42%14.71M13.18%16.31M-32.35%14.41M-41.09%13.38M
Current changes in cash 409.33%2.57M-84.85%1.04M-196.37%-4.73M167.67%5.08M-123.30%-682K113.74%504K277.44%6.86M-294.05%-1.6M127.57%1.9M135.25%2.93M
End cash Position -8.20%20.26M-17.95%17.69M13.24%16.66M31.17%21.39M31.17%21.39M64.97%22.07M26.52%21.57M-3.42%14.71M13.18%16.31M13.18%16.31M
Free cash flow 238.14%2.95M-82.33%1.26M-181.33%-4.36M197.10%6.04M-113.72%-388K123.58%873K317.82%7.1M-228.15%-1.55M125.48%2.03M133.78%2.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data